Andrew Ambrosy to Etiocholanolone
This is a "connection" page, showing publications Andrew Ambrosy has written about Etiocholanolone.
Connection Strength
0.025
-
Combining SERCA2a activation and Na-K ATPase inhibition: a promising new approach to managing acute heart failure syndromes with low cardiac output. Discov Med. 2011 Aug; 12(63):141-51.
Score: 0.025